vs

Side-by-side financial comparison of U S GLOBAL INVESTORS INC (GROW) and INVO Fertility, Inc. (IVF). Click either name above to swap in a different company.

U S GLOBAL INVESTORS INC is the larger business by last-quarter revenue ($2.5M vs $1.8M, roughly 1.4× INVO Fertility, Inc.). U S GLOBAL INVESTORS INC runs the higher net margin — -33.7% vs -150.5%, a 116.8% gap on every dollar of revenue. On growth, INVO Fertility, Inc. posted the faster year-over-year revenue change (22.6% vs 12.5%). Over the past eight quarters, INVO Fertility, Inc.'s revenue compounded faster (12.8% CAGR vs -1.6%).

Allianz Global Investors, is a global investment management firm with offices in over 20 locations worldwide. It is owned by the global financial services group Allianz. Employing nearly 3,000, it manages over EUR 500 billion in assets on behalf of institutional, retail clients and also of Allianz itself. AGI became known for one of the biggest fraud cases in which its Structured Alpha fund lost over 6 billion dollars in the 2020 market sell-off. As the risk profile of the fund was missold to...

INVO Fertility, Inc. is a specialized healthcare company focused on delivering accessible assisted reproductive technology solutions. It develops, manufactures and markets the patented INVOcell intravaginal culture system for in vitro fertilization procedures, serving fertility clinics and patients across North America, Europe and other global regions, with a mission to reduce barriers to high-quality fertility care.

GROW vs IVF — Head-to-Head

Bigger by revenue
GROW
GROW
1.4× larger
GROW
$2.5M
$1.8M
IVF
Growing faster (revenue YoY)
IVF
IVF
+10.1% gap
IVF
22.6%
12.5%
GROW
Higher net margin
GROW
GROW
116.8% more per $
GROW
-33.7%
-150.5%
IVF
Faster 2-yr revenue CAGR
IVF
IVF
Annualised
IVF
12.8%
-1.6%
GROW

Income Statement — Q2 FY2026 vs Q3 FY2025

Metric
GROW
GROW
IVF
IVF
Revenue
$2.5M
$1.8M
Net Profit
$-846.0K
$-2.6M
Gross Margin
Operating Margin
-3.5%
-93.1%
Net Margin
-33.7%
-150.5%
Revenue YoY
12.5%
22.6%
Net Profit YoY
-883.7%
-62.2%
EPS (diluted)
$-0.07
$-0.77

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GROW
GROW
IVF
IVF
Q4 25
$2.5M
Q3 25
$2.3M
$1.8M
Q2 25
$2.0M
$1.9M
Q1 25
$2.1M
$1.6M
Q4 24
$2.2M
$1.7M
Q3 24
$2.2M
$1.4M
Q2 24
$2.4M
$1.8M
Q1 24
$2.6M
$1.6M
Net Profit
GROW
GROW
IVF
IVF
Q4 25
$-846.0K
Q3 25
$1.5M
$-2.6M
Q2 25
$-5.3M
Q1 25
$-382.0K
$-17.4M
Q4 24
$-86.0K
$-3.6M
Q3 24
$315.0K
$-1.6M
Q2 24
$315.0K
$-2.2M
Q1 24
$-35.0K
$-1.6M
Gross Margin
GROW
GROW
IVF
IVF
Q4 25
Q3 25
Q2 25
Q1 25
35.2%
Q4 24
41.4%
Q3 24
31.0%
Q2 24
53.1%
Q1 24
45.3%
Operating Margin
GROW
GROW
IVF
IVF
Q4 25
-3.5%
Q3 25
-22.9%
-93.1%
Q2 25
-160.4%
Q1 25
-42.5%
-1042.1%
Q4 24
-24.2%
-202.0%
Q3 24
-25.9%
-90.7%
Q2 24
-100.9%
Q1 24
-18.8%
-95.7%
Net Margin
GROW
GROW
IVF
IVF
Q4 25
-33.7%
Q3 25
66.9%
-150.5%
Q2 25
-283.6%
Q1 25
-18.2%
-1060.1%
Q4 24
-3.9%
-211.3%
Q3 24
14.6%
-113.8%
Q2 24
12.9%
-122.2%
Q1 24
-1.3%
-101.3%
EPS (diluted)
GROW
GROW
IVF
IVF
Q4 25
$-0.07
Q3 25
$0.12
$-0.77
Q2 25
$-13.30
Q1 25
$-0.03
$-12.53
Q4 24
$-0.01
$14.86
Q3 24
$0.02
$-15.11
Q2 24
$0.01
$-22.39
Q1 24
$0.00
$-7.55

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GROW
GROW
IVF
IVF
Cash + ST InvestmentsLiquidity on hand
$34.4M
Total DebtLower is stronger
$2.0M
Stockholders' EquityBook value
$44.2M
$5.8M
Total Assets
$47.2M
$18.8M
Debt / EquityLower = less leverage
0.34×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GROW
GROW
IVF
IVF
Q4 25
$34.4M
Q3 25
$34.3M
Q2 25
$34.2M
Q1 25
$36.0M
Q4 24
$35.7M
Q3 24
$37.0M
Q2 24
$37.0M
Q1 24
$37.5M
Total Debt
GROW
GROW
IVF
IVF
Q4 25
Q3 25
$2.0M
Q2 25
$4.8M
Q1 25
Q4 24
$7.5M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
GROW
GROW
IVF
IVF
Q4 25
$44.2M
Q3 25
$46.0M
$5.8M
Q2 25
$45.2M
$2.6M
Q1 25
$46.1M
$3.3M
Q4 24
$47.3M
$12.7M
Q3 24
$48.4M
$-23.3K
Q2 24
$49.0M
$1.4M
Q1 24
$49.7M
$10.2K
Total Assets
GROW
GROW
IVF
IVF
Q4 25
$47.2M
Q3 25
$48.9M
$18.8M
Q2 25
$48.1M
$19.3M
Q1 25
$48.8M
$31.7M
Q4 24
$50.1M
$46.4M
Q3 24
$51.1M
$17.0M
Q2 24
$52.0M
$17.8M
Q1 24
$52.8M
$17.3M
Debt / Equity
GROW
GROW
IVF
IVF
Q4 25
Q3 25
0.34×
Q2 25
1.83×
Q1 25
Q4 24
0.59×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GROW
GROW
IVF
IVF
Operating Cash FlowLast quarter
$256.0K
$-1.8M
Free Cash FlowOCF − Capex
$-1.8M
FCF MarginFCF / Revenue
-101.6%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-7.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GROW
GROW
IVF
IVF
Q4 25
$256.0K
Q3 25
$-32.0K
$-1.8M
Q2 25
$-822.0K
$-1.7M
Q1 25
$-425.0K
$-3.5M
Q4 24
$-399.0K
$-617.4K
Q3 24
$16.0K
$-640.8K
Q2 24
$990.0K
$-1.5M
Q1 24
$-57.0K
$-260.6K
Free Cash Flow
GROW
GROW
IVF
IVF
Q4 25
Q3 25
$-1.8M
Q2 25
$-829.0K
$-1.7M
Q1 25
$-426.0K
$-3.6M
Q4 24
$-406.0K
$-696.3K
Q3 24
Q2 24
$777.0K
$-1.5M
Q1 24
$-125.0K
$-310.3K
FCF Margin
GROW
GROW
IVF
IVF
Q4 25
Q3 25
-101.6%
Q2 25
-42.3%
-92.6%
Q1 25
-20.3%
-216.9%
Q4 24
-18.2%
-40.6%
Q3 24
Q2 24
31.8%
-82.3%
Q1 24
-4.8%
-19.7%
Capex Intensity
GROW
GROW
IVF
IVF
Q4 25
Q3 25
0.5%
Q2 25
0.4%
0.5%
Q1 25
0.0%
0.9%
Q4 24
0.3%
4.6%
Q3 24
0.0%
0.0%
Q2 24
8.7%
3.0%
Q1 24
2.6%
3.2%
Cash Conversion
GROW
GROW
IVF
IVF
Q4 25
Q3 25
-0.02×
Q2 25
Q1 25
Q4 24
Q3 24
0.05×
Q2 24
3.14×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons